abaloparatide vs alendronate
Side-by-side comparison of abaloparatide and alendronate Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Tymlos
Fosamax
Tymlos is a medicine to treat osteoporosis. It helps make your bones stronger and less likely to break.
Binosto is a medicine that helps make your bones stronger. It is used to treat osteoporosis in women after menopause and in men.
Tymlos treats osteoporosis in women after menopause and in men. It is for people who have a high chance of breaking a bone. This includes those who have already had a bone break due to osteoporosis or have other risk factors. It can also be used if other osteoporosis treatments did not work or could not be tolerated.
Binosto treats osteoporosis, a condition that weakens bones and makes them more likely to break. It helps to increase bone mass in both postmenopausal women and men who have osteoporosis. Using this medicine can lower your chance of having fractures, including hip and spine fractures. Talk to your doctor about how long you should take this medicine.
Tymlos is similar to a natural hormone in your body. It helps your body build new bone. This makes your bones stronger and less likely to break.
Binosto belongs to a class of drugs called bisphosphonates. It works by slowing down the breakdown of bone in your body. This helps to increase bone density and reduce the risk of fractures.
- • High calcium in your urine
- • Feeling dizzy
- • Feeling sick to your stomach
- • Headache
- • Feeling your heart beat fast or irregularly
- • Abdominal pain
- • Acid reflux
- • Constipation
- • Diarrhea
- • Upset stomach
- Headache 4,180
- Feeling sick to your stomach 3,222
- Feeling dizzy 3,122
- Feeling tired 2,742
- Increased heart rate 2,139
- Pain 13,524
- Tiredness 12,776
- The medicine is not working 12,331
- Fracture of the thigh bone 11,334
- Joint pain 11,000
Tymlos may increase the risk of bone cancer (osteosarcoma). You should not take this medicine if you have certain conditions that increase this risk. These include Paget's disease, bone cancer, radiation treatment to your bones, or certain hereditary disorders. If you have symptoms of feeling dizzy, palpitations, tachycardia, or nausea, you should sit or lie down.
Binosto can cause problems with your esophagus. Follow the directions for taking it carefully. If you have new or worsening heartburn, pain when swallowing, or chest pain, stop taking Binosto and call your doctor. This medicine may also cause severe bone, joint, or muscle pain. If you develop these symptoms, stop taking Binosto and contact your doctor.
Tymlos is not for women who could get pregnant. It is not known if Tymlos can harm an unborn baby or pass into breast milk.
Stop taking Binosto if you become pregnant. Bisphosphonates can stay in your bones for many years and could potentially harm the baby's skeleton.
Also Compare — Nearby Drugs
Compare alendronate with
How to Read This abaloparatide vs alendronate Comparison
abaloparatide is classified in the PTHrP Analog drug class, while alendronate sits within the Bisphosphonate class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, abaloparatide has 15,405 submissions while alendronate has 60,965. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between abaloparatide and alendronate — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.